awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36565628-29252F1F-BDAE-42A0-B5DC-1E4D47053F8C
Q36565628-29252F1F-BDAE-42A0-B5DC-1E4D47053F8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36565628-29252F1F-BDAE-42A0-B5DC-1E4D47053F8C
The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide mai
P2860
Q36565628-29252F1F-BDAE-42A0-B5DC-1E4D47053F8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36565628-29252F1F-BDAE-42A0-B5DC-1E4D47053F8C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
74c8789d5860384ec968d6dceb276172d3f5ff05
P2860
The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation.